AI assistant
Sending…
CORCEPT THERAPEUTICS INC — Director's Dealing 2021
May 28, 2021
30681_dirs_2021-05-28_c7863806-c70f-4c4b-88a1-ba1b998712e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-05-26
Reporting Person: MAHONEY DAVID L (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-26 | Stock Option (Right to Buy) | $21.45 | A | 20000 | Acquired | 2031-05-25 | Common Stock (20000) | Direct |
Footnotes
F1: Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over a one-year period.
More from CORCEPT THERAPEUTICS INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18